TURNING P THERAPEUTICSCS INC
TURNING P THERAPEUTICSCS INC
Aktie · US90041T1088 · TPTX (XNAS)
Übersicht Finanzkennzahlen
Kein Kurs
n/a

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
- - - - 0,00 % 0,00 % 20,69 %

Firmenprofil zu TURNING P THERAPEUTICSCS INC Aktie

Turning Point Therapeutics, Inc., a clinical-stage precision oncology biopharmaceutical company, engages in designing and developing therapies that target genetic drivers of cancer. It develops a pipeline of tyrosine kinase inhibitors (TKIs) that targets genetic drivers of cancer in TKI-naïve and TKI-pretreated patients. The company's lead drug candidate repotrectinib is being evaluated in an ongoing Phase 1/2 trial called TRIDENT-1 for the treatment of patients with ROS1+ advanced non-small-cell lung cancer (NSCLC) and patients with ROS1+ and NTRK+ advanced solid tumors. It also develops TPX-0022, a MET/SRC/CSF1R inhibitor, which is in Phase 1 SHIELD-1 clinical trial for patients with advanced solid tumors harboring genetic alterations in MET; TPX-0046, a RET inhibitor that is in 1/2 SWORD-1 clinical trial for patients with advanced solid tumors harboring RET genetic alterations; and TPX-0131, an ALK inhibitor, which is in Phase 1/2 FORGE-1 study for patient with advanced or metastatic TKI-pretreated ALK-positive NSCLC. Turning Point Therapeutics, Inc. was founded in 2013 and is headquartered in San Diego, California. As of August 15, 2022, Turning Point Therapeutics, Inc. operates as a subsidiary of Bristol-Myers Squibb Company.

Investierte Fonds

Folgende Fonds haben in investiert: TURNING P THERAPEUTICSCS INC investiert:

Fonds
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in Mio
133,39
Anteil (%)
0,31 %

Unternehmensdaten

Name TURNING P THERAPEUTICSCS INC
Firma Turning Point Therapeutics, Inc.
Symbol TPTX
Website https://www.tptherapeutics.com
Heimatbörse XNAS NASDAQ
ISIN US90041T1088
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Dr. Athena Maria Countouriotis
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,3 T
Adresse 10628 Science Center Dr Ste 200, 92121 San Diego
IPO Datum 2019-04-17

Ticker Symbole

Name Symbol
NASDAQ TPTX

Weitere Aktien

Investoren die TURNING P THERAPEUTICSCS INC die halten, haben auch folgende Aktien im Depot:
AMGEN INC
AMGEN INC Aktie
ARRAN RESIDENTIAL MORTGAGES FUNDING NO.2 PLC CLS BC AST BKD FRN 20/09/56 144A EUR
ARRAN RESIDENTIAL MORTGAGES FUNDING NO.2 PLC CLS BC AST BKD FRN 20/09/56 144A EUR Anleihe
AUTODESK INC
AUTODESK INC Aktie
CISCO SYSTEMS INC
CISCO SYSTEMS INC Aktie
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Aktie
ELECTRONIC ARTS INC
ELECTRONIC ARTS INC Aktie
FTC SOLAR INC
FTC SOLAR INC Aktie
INTEL CORP
INTEL CORP Aktie
JPMORGAN CHASE & CO
JPMORGAN CHASE & CO Aktie
KOREA EXPRESS. 17/32 MTN
KOREA EXPRESS. 17/32 MTN Anleihe
MICROSOFT CORP
MICROSOFT CORP Aktie
NXP SEMICONDUCTORS NV
NXP SEMICONDUCTORS NV Aktie
ROB.CGF-R.BP US PR.EQ.DDL
ROB.CGF-R.BP US PR.EQ.DDL Fonds
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025